Related references
Note: Only part of the references are listed.PCDH7 knockdown potentiates colon cancer cells to chemotherapy via inducing ferroptosis and changes in autophagy through restraining MEK1/2/ERK/c-Fos axis
Zhendong Liu et al.
BIOCHEMISTRY AND CELL BIOLOGY (2022)
The predictive prognostic values of CBFA2T3, STX3, DENR, EGLN1, FUT4, and PCDH7 in lung cancer
Yuhao Chen et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Colorectal cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Intracellular levels of reactive oxygen species correlate with ABT-263 sensitivity in non-small-cell lung cancer cells
Keiko Ohgino et al.
CANCER SCIENCE (2020)
RAS-targeted therapies: is the undruggable drugged?
Amanda R. Moore et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Protocadherin-7 contributes to maintenance of bone homeostasis through regulation of osteoclast multinucleation
Hyunsoo Kim et al.
BMB REPORTS (2020)
Selective targeting of antiapoptotic BCL-2 proteins in cancer
Ahmet Can Timucin et al.
MEDICINAL RESEARCH REVIEWS (2019)
Protocadherin γ-A7 is down-regulated in colorectal cancer and associated with the prognosis in patients with wild-type KRAS
Yingdi Liu et al.
HUMAN PATHOLOGY (2019)
Allosteric modulation of sigma receptors by BH3 mimetics ABT-737, ABT-263 (Navitoclax) and ABT-199 (Venetoclax)
John R. Lever et al.
PHARMACOLOGICAL RESEARCH (2019)
Modulation of Mutant KrasG12D-Driven Lung Tumorigenesis In Vivo by Gain or Loss of PCDH7 Function
Xiaorong Zhou et al.
MOLECULAR CANCER RESEARCH (2019)
New therapies and insights into the changing landscape of colorectal cancer
Scott Kopetz
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis
Xiaorong Zhou et al.
CANCER RESEARCH (2017)
Therapeutic Potential of Targeting Wnt/-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress
Afsane Bahrami et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Protocadherin 7 inhibits cell migration and invasion through E-cadherin in gastric cancer
Hong-Fang Chen et al.
TUMOR BIOLOGY (2017)
CCAAT enhancer binding protein β has a crucial role in regulating breast cancer cell growth via activating the TGF-β-Smad3 signaling pathway
Jing Cao et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
The Rising Incidence of Younger Patients With Colorectal Cancer: Questions About Screening, Biology, and Treatment
Louise C. Connell et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2017)
Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies
Giuseppa Pistritto et al.
AGING-US (2016)
Low expression of protocadherin7 (PCDH7) is a potential prognostic biomarker for primary non-muscle invasive bladder cancer
Ying-Li Lin et al.
ONCOTARGET (2016)
Anticancer bioactive peptides suppress human colorectal tumor cell growth and induce apoptosis via modulating the PARP-p53-Mcl-1 signaling pathway
Li-ya Su et al.
ACTA PHARMACOLOGICA SINICA (2015)
Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies
Sabine Venderbosch et al.
CLINICAL CANCER RESEARCH (2014)
Protocadherin-7 induces bone metastasis of breast cancer
Ai-Min Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
Protocadherin-PC promotes androgen-independent prostate cancer cell growth
Stephane Terry et al.
PROSTATE (2006)